Your browser doesn't support javascript.
loading
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Antonetti, Paolo; Fargnoli, Maria Concetta; Porzio, Giampiero; Salvatore, Lisa; Filippi, Roberto; Ghidini, Michele; Nigro, Olga; Gelsomino, Fabio; Zurlo, Ina Valeria; Dell'Aquila, Emanuela; Lombardi, Pasquale; Keränen, Susana Roselló; Depetris, Ilaria; Giampieri, Riccardo; Morelli, Cristina; De Tursi, Michele; Di Pietro, Francesca Romana; Zanaletti, Nicoletta; Vitale, Pasquale; Garajova, Ingrid; Spinelli, Gian Paolo; Zoratto, Federica; Roberto, Michela; Petrillo, Angelica; Aimar, Giacomo; Cortellini, Alessio; Pensieri, Maria Vittoria; Ficorella, Corrado; Ferri, Claudio; Parisi, Alessandro.
Afiliação
  • Antonetti P; Dermatology, St. Salvatore Hospital, L'Aquila, Italy.
  • Fargnoli MC; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, Coppito 2, 67100, L'Aquila, Italy.
  • Porzio G; Dermatology, St. Salvatore Hospital, L'Aquila, Italy. fargnoli@univaq.it.
  • Salvatore L; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, Coppito 2, 67100, L'Aquila, Italy. fargnoli@univaq.it.
  • Filippi R; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, Coppito 2, 67100, L'Aquila, Italy.
  • Ghidini M; Medical Oncology, St. Salvatore Hospital, L'Aquila, Italy.
  • Nigro O; Università Cattolica del Sacro Cuore, Rome, Italy.
  • Gelsomino F; Medical Oncology, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy.
  • Zurlo IV; Department of Oncology, University of Turin, Torino, Italy.
  • Dell'Aquila E; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, TO, Italy.
  • Lombardi P; Centro Oncologico Ematologico Subalpino, Azienda Universitaria Ospedaliera Città della Salute e della Scienza di Torino, Torino, Italy.
  • Keränen SR; Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
  • Depetris I; Medical Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy.
  • Giampieri R; Department of Oncology and Hematology, Division of Oncology, University Hospital of Modena, Modena, Italy.
  • Morelli C; Medical Oncology, "Vito Fazzi" Hospital, Lecce, Italy.
  • De Tursi M; Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Di Pietro FR; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain.
  • Zanaletti N; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
  • Vitale P; Medical Oncology, ASL TO4, Ospedale Civile di Ivrea, Ivrea, Turin, Italy.
  • Garajova I; Clinica Oncologica e Centro Regionale di Genetica Oncologica, Università Politecnica delle Marche, AOU Ospedali Riuniti, Ancona, Italy.
  • Spinelli GP; Medical Oncology Unit and PhD program in Systems and Experimental Medicine (XXXV cycle), Tor Vergata University Hospital, Viale Oxford, 81, 00133, Rome, Italy.
  • Zoratto F; Department of Medical, Oral and Biotechnological Sciences and Center for Advance Studies and Technology (CAST), G. D'Annunzio University, Chieti, Italy.
  • Roberto M; Clinical Oncology Unit, S.S. Annunziata Hospital, Chieti, Italy.
  • Petrillo A; IRCCS Istituto Dermopatico dell'Immacolata (IDI), Rome, Italy.
  • Aimar G; Experimental Clinical Abdominal Oncology Unit, Istituto Nazionale Tumori-IRCCS-Fondazione G.Pascale, Napoli, Italy.
  • Cortellini A; Department of Precision Medicine, Università della Campania "Luigi Vanvitelli", 80131, Napoli, Italy.
  • Pensieri MV; Medical Oncology Unit, Santa Chiara Hospital, Trento, Italy.
  • Ficorella C; Medical Oncology Unit, University Hospital of Parma, Via Gramsci 14, 43126, Parma, Italy.
  • Ferri C; UOC Territorial Oncology - AUSL Latina-CdS Aprilia - University of Rome "Sapienza", Latina, Italy.
  • Parisi A; Medical Oncology, Santa Maria Goretti Hospital, Latina, Italy.
Support Care Cancer ; 30(3): 2455-2465, 2022 Mar.
Article em En | MEDLINE | ID: mdl-34779921
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas Proto-Oncogênicas B-raf Tipo de estudo: Clinical_trials / Guideline Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália País de publicação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas Proto-Oncogênicas B-raf Tipo de estudo: Clinical_trials / Guideline Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália País de publicação: Alemanha